a developer of peptide therapeutics for metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with RCKT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then RCKT could also see price increases.
Ticker / NAME | Correlation To RYTM | 1D Price Change % | ||
---|---|---|---|---|
RYTM | 100% | -6.23% | ||
RCKT - RYTM | 52% Loosely correlated | -2.25% | ||
ERAS - RYTM | 43% Loosely correlated | -4.68% | ||
BPMC - RYTM | 43% Loosely correlated | +0.27% | ||
KURA - RYTM | 43% Loosely correlated | -4.42% | ||
PLRX - RYTM | 43% Loosely correlated | -0.36% | ||
More |
Ticker / NAME | Correlation To RYTM | 1D Price Change % |
---|---|---|
RYTM | 100% | -6.23% |
peptide theme (2 stocks) | 99% Closely correlated | -5.54% |
drugs theme (254 stocks) | 49% Loosely correlated | -0.52% |
metabolic theme (5 stocks) | 40% Loosely correlated | +0.81% |
biotechnology theme (238 stocks) | 29% Poorly correlated | -0.62% |